Quick Takeaways
- MAVERICK CAPITAL LTD filed SCHEDULE 13G/A for Verona Pharma Plc Ordinary Shares, nominal value 0.05 GBP per share (VRNA).
- Disclosed ownership: 3.8%.
- Date of event: 31 Dec 2024.
MAVERICK CAPITAL LTD - 31 Dec 2024 SCHEDULE 13G/A Report for Verona Pharma Plc Ordinary Shares, nominal value 0.05 GBP per share (VRNA)
- Filing Manager
- MAVERICK CAPITAL LTD
- Reporting Manager
- Maverick Capital, Ltd.
- Symbol
- VRNA
- Shares outstanding
- 658,634,947 shares
- Disclosed Ownership
- 25,028,128 shares
- Ownership
- 3.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 16:15:03 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"MAVERICK CAPITAL LTD disclosed 3.8% ownership in Verona Pharma Plc Ordinary Shares, nominal value 0.05 GBP per share (VRNA) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Maverick Capital, Ltd. | 3.8% | 25,028,128 | 0 | 25,028,128 | /s/ Trevor Wiessmann* | By: Maverick Capital Management, LLC, its General Partner By: Lee S. Ainslie III, Manager | |
| Maverick Capital Management, LLC | 3.8% | 25,028,128 | 0 | 25,028,128 | /s/ Trevor Wiessmann* | Lee S. Ainslie III, Manager | |
| Lee S. Ainslie III | 3.8% | 25,028,128 | 0 | 25,028,128 | /s/ Trevor Wiessmann* | Lee S. Ainslie III, Manager |